Otsuka Holdings Co., Ltd.: all 780 studies

Page 8 of 8. Open to participants first (58), then studies with results posted, then the rest; newest registration first within each.

• Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal CancerCompletedNCT00284258Phase 2/3
• Aripiprazole in the Treatment of Acutely Relapsed Patients With SchizophreniaCompletedNCT00283179Phase 3
• Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication TherapyCompletedNCT00272467Phase 4
• Cilostazol in Acute Ischemic Stroke Treatment (CAIST)CompletedNCT00272454Phase 4
• Study of Aripiprazole in Patients With Bipolar I DisorderCompletedNCT00257972Phase 3
• A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric PracticesCompletedNCT00237939Phase 3
• Schizophrenia Trial of AripiprazoleCompletedNCT00237913Phase 3
• A Switch Study of BMS-337039 in Schizophrenic Out-patientsCompletedNCT00232687Phase 4
• Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -CompletedNCT00229424Phase 3
• Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205)CompletedNCT00219414Phase 4
• Efficacy and Safety of Cilostazol for the Indication of CSPSCompletedNCT00216749
• Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar DisorderCompletedNCT00216723
• Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric CancerCompletedNCT00202969Phase 3
• Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of StrokeCompletedNCT00202020Phase 3
• Efficacy and Safety Study of Aripiprazole to Treat SchizophreniaCompletedNCT00202007Phase 2
• Study of Ascending Levels of Tolvaptan in HyponatremiaCompletedNCT00201994Phase 3
• A 1-Year Study in Multiple Clinics Testing Rebamipide Eye Drops for Dry Eye Compared With a PlaceboCompletedNCT00201981Phase 3
• Study of Rebamipide Eye Drops to Treat Dry EyeCompletedNCT00201955Phase 3
• A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)CompletedNCT00152243Phase 3
• A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)CompletedNCT00152230Phase 3
• Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)CompletedNCT00152217Phase 3
• A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)CompletedNCT00152191Phase 3
• The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)CompletedNCT00152178Phase 3
• Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric CancerCompletedNCT00150670Phase 3
• Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart FailureCompletedNCT00132886Phase 2
• Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic NeuropathyCompletedNCT00113620Phase 3
• Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic CancerTerminatedNCT00113256Phase 2/3
• Study of Rubitecan in Cancer Patients With Renal or Hepatic DysfunctionCompletedNCT00113113Phase 1
• Study for the Treatment of Ulcerative Colitis With AdacolumnCompletedNCT00102193Phase 3
• Aripiprazole Oral Acceptability TrialCompletedNCT00101569Phase 3
• Study of Aripiprazole in Patients With Acute Bipolar ManiaCompletedNCT00097266Phase 3
• A Study of Adjunctive Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00095823Phase 3
• Aripiprazole in Patients With Psychosis Associated With Parkinson's DiseaseCompletedNCT00095810Phase 4
• A Study of Adjunctive Aripiprazole in Participants With Major Depressive DisorderCompletedNCT00095758Phase 3
• A Long-Term Study of Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00095745Phase 3
• Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With DementiaCompletedNCT00095719Phase 3
• Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective DisorderCompletedNCT00095524Phase 3
• Aripiprazole in Patients With Acute ManiaCompletedNCT00095511Phase 3
• A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive EpisodeCompletedNCT00094432Phase 3
• CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) RemissionCompletedNCT00092508Phase 3
• Study of Aripiprazole in Subjects With AlcoholismCompletedNCT00082199Phase 4
• Study of Three Doses of Aripiprazole in Patients With Acute SchizophreniaCompletedNCT00080327Phase 4
• Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression EpisodeCompletedNCT00080314Phase 3
• Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric CancerCompletedNCT00072787Phase 1/2
• "SALT Trial" Study of Ascending Levels of Tolvaptan in HyponatremiaCompletedNCT00072683Phase 3
• EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With TolvaptanCompletedNCT00071331Phase 3
• FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative ColitisCompletedNCT00064454Phase 3
• FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative ColitisCompletedNCT00064441Phase 3
• Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)CompletedNCT00056524Phase 3
• Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis PatientsCompletedNCT00050232Phase 3
• Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonCompletedNCT00048776Phase 4
• Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonCompletedNCT00048763Phase 4
• Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar DisorderCompletedNCT00046384Phase 3
• Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure PatientsCompletedNCT00043771Phase 2
• Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure PatientsCompletedNCT00043758Phase 2
• Decitabine Versus Supportive Care in Adults With Advanced-stage MDSCompletedNCT00043381Phase 3
• Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)CompletedNCT00042016Phase 2
• Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)CompletedNCT00042003Phase 2
• Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)CompletedNCT00041990Phase 2
• Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeCompletedNCT00041678Phase 3
• Broad Effectiveness: Study With AripiprazoleCompletedNCT00036361Phase 3
• Study of Aripiprazole in Patients With a History of Bipolar DisorderCompletedNCT00036348Phase 3
• Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic DisordersCompletedNCT00036127Phase 2/3
• Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeCompletedNCT00036114Phase 3
• Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar DisorderCompletedNCT00036101Phase 3
• Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHDTerminatedNCT00032773Phase 1/2
• Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALSCompletedNCT00021697Phase 3
• Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal CancerStatus unknownNCT00005877Phase 2
• Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During SurgeryStatus unknownNCT00005876Phase 2
• Nitrocamptothecin in Treating Patients With Metastatic MelanomaCompletedNCT00005875Phase 2
• Nitrocamptothecin in Treating Patients With Soft Tissue SarcomasCompletedNCT00005874Phase 2
• Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00005873Phase 2
• Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung CancerCompletedNCT00005872Phase 2
• Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic CancerStatus unknownNCT00005871Phase 3
• Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the PancreasStatus unknownNCT00005870Phase 3
• Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic CancerStatus unknownNCT00005869Phase 3
• A Study of Multiple Doses of Vesnarinone in Advanced HIV DiseaseCompletedNCT00002337Phase 1
• A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's SarcomaCompletedNCT00002131Phase 2
• A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected PersonsCompletedNCT00002130Not applicable
• A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3CompletedNCT00002129Phase 1

← Otsuka Holdings Co., Ltd. overview and focus areas